Ozempic (semaglutide) supply shortage
Submitted by Anonymous (not verified) on 15 December 2023 - 10:12
Ozempic (semaglutide) supply shortage
Victoza (liraglutide) supply shortage
Submitted by Anonymous (not verified) on 15 December 2023 - 10:00
Victoza (liraglutide) supply shortage
CVMP work plan 2024
Submitted by Anonymous (not verified) on 15 December 2023 - 9:08
CVMP work plan 2024
Management Board meeting: 13-14 December 2023, European Medicines Agency, Amsterdam, the Netherlands, from 13 December 2023 to 14 December 2023
Submitted by Anonymous (not verified) on 15 December 2023 - 8:23
Management Board meeting: 13-14 December 2023, European Medicines Agency, Amsterdam, the Netherlands, from 13 December 2023 to 14 December 2023
Mock-ups for veterinary medicines
Submitted by Anonymous (not verified) on 14 December 2023 - 16:30
Mock-ups for veterinary medicines
Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Date of authorisation: 27/11/1995, Revision: 51, Status: Authorised
Submitted by Anonymous (not verified) on 14 December 2023 - 16:14
Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Date of authorisation: 27/11/1995, Revision: 51, Status: Authorised
Management Board meeting: 5 October 2023, European Medicines Agency, Amsterdam, the Netherlands, 5 October 2023
Submitted by Anonymous (not verified) on 14 December 2023 - 15:13
Management Board meeting: 5 October 2023, European Medicines Agency, Amsterdam, the Netherlands, 5 October 2023
Worksharing of variations (veterinary medicines)
Submitted by Anonymous (not verified) on 14 December 2023 - 12:26
Worksharing of variations (veterinary medicines)
Variations requiring assessment (veterinary medicines)
Submitted by Anonymous (not verified) on 14 December 2023 - 12:17
Variations requiring assessment (veterinary medicines)
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Status: Withdrawn application
Submitted by Anonymous (not verified) on 14 December 2023 - 12:12
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Status: Withdrawn application